| Filed On | Filing |
|---|---|
| 23 Jul 2026 |
Form 3: Eli Lilly & Co, 10% owner
Holds 1,054,828 shares of Common Stock |
| 23 Jul 2026 | Form 3: Ah Bio Fund II, L.p., 10% owner and 5 others |
| 23 Jul 2026 | Form 3: Orbimed Advisors Llc, Director and 1 other |
| 23 Jul 2026 | Form 3: Gordon Carl L, Director |
| 23 Jul 2026 |
Form 3: Staahl Brett, 10% owner
Holds 524,336 shares of Common Stock |
| 23 Jul 2026 |
Form 3: Doudna Jennifer A, 10% owner
Holds 591,036 shares of Common Stock |
| 23 Jul 2026 |
Form 3: Watson James Dean, Director
No securities owned |
| 23 Jul 2026 |
Form 3: Lucas Svetlana, Chief Business Officer
Holds 30,695 shares of Common Stock |
| 23 Jul 2026 |
Form 3: Bleharski Joshua, Director
No securities owned |
| 23 Jul 2026 |
Form 3: Oakes Benjamin L., Director
Holds 506,602 shares of Common Stock |
| 23 Jul 2026 | Form 3: Parrot David, Chief Financial Officer |
| 23 Jul 2026 |
Form 3: Aghazadeh Behzad, Director and 2 others
Holds 697,650 shares of Common Stock, par value $0.0001 per share |
Loading...